Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06377215 · ClinicalTrials.gov registry record · NA

Understanding Aided Speech Perception in Noise

A NA study of Aging and Hearing Aids, sponsored by University of South Florida.

Recruiting
Registry status
NA
Development phase
121
Enrollment target
1
Study location

NCT06377215: Recruiting NA study of Aging and Hearing Aids, sponsored by University of South Florida.

NCT06377215 is a NA study of Aging and Hearing Aids that is actively recruiting participants, run by University of South Florida. The registered enrollment target is 121 participants, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06377215, a NA study of Aging and Hearing Aids, is actively recruiting participants, sponsored by University of South Florida.

RECRUITING
Registry status
NA
Development phase
121 participants
Enrollment target
1
Study location

Study Summary

The overarching hypothesis to be evaluated using this protocol is that age-related hearing loss (ARHL) leads to shifts in the functional spatial boundaries between segregated and integrated auditory streams, and that hearing aid intervention that relies on directional processing schemes is most effective for those that have the poorest spatial sensitivity. One key component of the research design is to measure both behavioral and neurophysiological indices of an individual's spatial segregation boundary. The second key component is to measure the cost or benefit associated with hearing aid intervention in older hearing-impaired listeners. The final component is to relate cost and benefit of hearing aid intervention to spatial sensitivity measures that might predict the efficacy of clinical intervention.

Primary Outcome

The investigators will measure the behavioral accuracy of listeners identifying digits in a continuous stream of monosyllabic words. In a roughly two-minute run, about 30 digits are presented and listeners are tasked with immediately identifying each one as they are presented. The target stream can be stationary or moving in space, and the masker speech stream can be stationary at the front loudspeaker or diffused around the front speaker (i.e., played from multiple speakers). For static or fixe

Interventions

  • DEVICE Open-source master hearing aid

Study Locations (1)

Florida

  • USF Research Park BPB, 3802 Spectrum Boulevard, Suite 210C - Tampa

Trial Details

FieldValue
Enrollment Target 121 participants
Start Date 2025-11-16
Est. Completion 2028-03-01
Phase NA
University of South Florida

252 total trials

What NCT06377215 shows while recruiting

NCT06377215 is an interventional study that assigns participants to a tested intervention. The registered 121 participants enrollment target is mid-sized for trials with a published cap, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (94% lower).

The record links to 4 conditions, with Aging appearing as the primary indexed condition, and to 1 intervention - of which Open-source master hearing aid is the first listed.

NCT06377215 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT06377215 about?

NCT06377215 is a clinical study titled "Understanding Aided Speech Perception in Noise". The overarching hypothesis to be evaluated using this protocol is that age-related hearing loss (ARHL) leads to shifts in the functional spatial boundaries between segregated and integrated auditory streams, and that hearing aid intervention that relies on directional processing schemes is most effe...

What is the current status of trial NCT06377215?

This trial is currently recruiting. It is a NA study. The enrollment target is 121 participants. The study started on 2025-11-16. Estimated completion is 2028-03-01.

What conditions does trial NCT06377215 study?

This clinical trial studies the following conditions: Aging, Hearing Aids, Hearing Impairment, Sensorineural, Spatial Perception.

What interventions are being tested in trial NCT06377215?

The interventions under investigation include: Open-source master hearing aid (DEVICE).

Who is sponsoring clinical trial NCT06377215?

This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06377215 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06377215's enrollment target sits among peer trials

121 69th of 262 higher than 194 of 262 other Aging trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03476681 · 121 participants · Phase 1

    Study of NEO-201 in Solid Tumors Expansion Cohorts

  • NCT04655118 · 121 participants · Phase 2

    Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis

  • NCT04676802 · 121 participants · Phase 2

    Pain Relief After Trapeziectomy: Ibuprofen & Acetaminophen Versus Oxycodone

  • NCT05169515 · 121 participants · Phase 1

    A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06377215, the US trial registry maintained by the National Library of Medicine. NCT06377215 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.